Leach RJ - Search Results

1

DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.

Horning AM, Awe JA, Wang CM, Liu J, Lai Z, Wang VY, Jadhav RR, Louie AD, Lin CL, Kroczak T, Chen Y, Jin VX, Abboud-Werner SL, Leach RJ, Hernandez J, Thompson IM, Saranchuk J, Drachenberg D, Chen CL, Mai S, Huang TH. Horning AM, et al. Among authors: leach rj. Prostate. 2015 Nov;75(15):1790-801. doi: 10.1002/pros.23052. Epub 2015 Sep 1. Prostate. 2015. PMID: 26332453

2

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Balic I, et al. Among authors: leach rj. J Urol. 2002 Nov;168(5):2245-8. doi: 10.1016/S0022-5347(05)64364-9. J Urol. 2002. PMID: 12394768

3

Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.

Thompson IM, Basler JA, Leach R, Troyer D, Klein E, Brawley O. Thompson IM, et al. Urol Oncol. 2003 Jan-Feb;21(1):73-8. doi: 10.1016/s1078-1439(02)00302-2. Urol Oncol. 2003. PMID: 12684131 Review.

4

Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.

Leach R, Pollock B, Basler J, Troyer D, Naylor S, Thompson IM. Leach R, et al. Urol Clin North Am. 2003 May;30(2):227-37. doi: 10.1016/s0094-0143(02)00178-7. Urol Clin North Am. 2003. PMID: 12735500 Review.

5

Prostate cancer and prostate-specific antigen: the more we know, the less we understand.

Thompson I, Leach RJ, Pollock BH, Naylor SL. Thompson I, et al. Among authors: leach rj. J Natl Cancer Inst. 2003 Jul 16;95(14):1027-8. doi: 10.1093/jnci/95.14.1027. J Natl Cancer Inst. 2003. PMID: 12865440 No abstract available.

6

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B. Thompson IM, et al. Clin Prostate Cancer. 2003 Mar;1(4):215-20. doi: 10.3816/cgc.2003.n.002. Clin Prostate Cancer. 2003. PMID: 15040879 Review.

7

Relationship of body mass index and prostate specific antigen in a population-based study.

Thompson IM, Leach R, Troyer D, Pollock B, Naylor S, Higgins B. Thompson IM, et al. Urol Oncol. 2004 Mar-Apr;22(2):127-31. doi: 10.1016/S1078-1439(03)00171-6. Urol Oncol. 2004. PMID: 15082010

8

Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men.

Hernández J, Balic I, Johnson-Pais TL, Higgins BA, Torkko KC, Thompson IM, Leach RJ. Hernández J, et al. Among authors: leach rj. J Urol. 2006 Feb;175(2):523-7. doi: 10.1016/S0022-5347(05)00240-5. J Urol. 2006. PMID: 16406987

9

Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.

Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D, Xiang R, Leach RJ, Johnson-Pais TL, Naylor SL. Vijayakumar S, et al. Among authors: leach rj. Cancer Res. 2006 Apr 15;66(8):4055-64. doi: 10.1158/0008-5472.CAN-05-3822. Cancer Res. 2006. PMID: 16618725

10

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM. Baillargeon J, et al. Among authors: leach rj. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5. doi: 10.1158/1055-9965.EPI-06-0082. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page